Statewide Success of Staged Sacral Neuromodulation for the Treatment of Urinary Complaints in California (2005–2011)

Abstract

The "real world" success rates for staged SNS implantation in California are less than those observed by some academic centers of excellence but better than previously reported for Medicare beneficiaries. Successful trial rates for interstitial cystitis and neurogenic voiding dysfunction are similar to refractory overactive bladder.